Outcome after device implantation in chronic heart failure is dependent on concomitant medical treatment

European Journal of Clinical Investigation

Volumn 39, Issue 12, 2009, Pages 1073-1081

  Adlbrecht, C ^a   Hulsmann M ^a   Gwechenberger, M ^a   Strunk, G ^b   Khazen, C ^a   Wiesbauer, F ^a   Elhenicky, M ^a   Neuhold, S ^a   Binder, T ^a   Maurer, G ^a   Lang, I M ^a   Pacher, R ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b VIENNA UNIVERSITY OF ECONOMICS AND BUSINESS   (Austria)

Author keywords

Cardiac resynchronization; Device therapy; Heart failure; Medical therapy; Outcome

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE FREE SURVIVAL; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIAC PACING, ARTIFICIAL; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 70449562564     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02217.x     Document Type: Article

References (22)

1. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005 352 : 1539 1549. (Pubitemid 40517094)
2. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004 350 : 2140 2150.
3. Auricchio A, Metra M, Gasparini M, Lamp B, Klersy C, Curnis A et al. Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization ztherapy. Am J Cardiol 2007 99 : 232 238.
4. Pietrasik G, Goldenberg I, McNitt S, Polonsky B, Moss AJ, Zareba W. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators. J Cardiovasc Electrophysiol 2009 20 : 395 400.
5. Fowler MB, Lottes SR, Nelson JJ, Lukas MA, Gilbert EM, Greenberg B et al. Beta-blocker dosing in community-based treatment of heart failure. Am Heart J 2007 153 : 1029 1036.
6. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000 342 : 1878 1886.
7. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000 342 : 1887 1892.
8. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008 29 : 2388 2442.
9. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996 335 : 1933 1940.
10. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function - measured and estimated glomerular filtration rate. N Engl J Med 2006 354 : 2473 2483.
11. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007 53 : 766 772.
12. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll zCardiol 2008 51 : 288 296.
13. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999 353 : 9 13.
14. Lenzen MJ, Boersma E, Reimer WJ, Balk AH, Komajda M, Swedberg K et al. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur Heart J 2005 26 : 2706 2713.
15. Lainscak M, Cleland JG, Lenzen MJ, Follath F, Komajda M, Swedberg K. International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey. Eur J Heart Fail 2007 9 : 292 299.
16. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 346 : 877 883.
17. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008 359 : 1009 1017.
18. Brodine WN, Tung RT, Lee JK, Hockstad ES, Moss AJ, Zareba W et al. Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II). Am J Cardiol 2005 96 : 691 695.
19. Pieragnoli P, Ricciardi G, Colella A, Musilli N, Porciani MC, Giaccardi M et al. Is implantable defibrillator indicated in all patients on cardiac resynchronization therapy? Minerva Cardioangiol 2006 54 : 735 741.
20. Myerburg RJ. Implantable cardioverter-defibrillators after myocardial infarction. N Engl J Med 2008 359 : 2245 2253.
21. Hreybe H, Ezzeddine R, Bedi M, Barrington W, Bazaz R, Ganz LI et al. Renal insufficiency predicts the time to first appropriate defibrillator shock. Am Heart J 2006 151 : 852 856.
22. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002 105 : 2392 2397.